Please assess the completion status of the following clinical trial:

Trial Title: Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Cases poisoned with a toxic agent within 3 months~* Patients with BCVA better than 35 letters~* Any degree of visual field loss~* Patients over 18 years old~Exclusion Criteria:~* Cases poisoned with a toxic agent more than 3 months~* Patients with BCVA less than 35 letters: to perform the visual field test correctly~* Neurological sequelae that cannot be cooperated~* Smoking

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- WJ-MSC combine witf rEMS (Type: ACTIVE_COMPARATOR): WJ-MSC was applied first to the patients after necessary preparations. rEMS application was started 10 days after WJ-MSC application.
- Only rEMS (Type: ACTIVE_COMPARATOR): rEMS applications were repeated 10 times with a 1-week interval.
- Only WJ-MSC (Type: ACTIVE_COMPARATOR): WJ-MSC was applied only one time for both eyes.

Based on this trial design, predict the completion outcome and termination type (if applicable).